Skip to Content

Eyelash Lengthener

February 24, 2009

Women who want longer lashes now have an alternative to messy mascara. Latisse, a version of a drug developed for glaucoma, was recently approved by the U.S. Food and Drug Administration to promote eyelash growth. Latisse is dabbed along the base of the eyelashes and must be applied daily, or its lash-­thickening effect will wear off. Available only by prescription, it has some potential side effects, including eye redness, itchy eyes, and discoloration of the eyelid.

Courtesy of Allergan

Product: Latisse

Cost: $120 for a 30-day supply

Source: www.latisse.com

Company: Allergan

Other products in this section:

180° Surveillance Camera

Volume-Limiting Headphones

3-D Webcam

Keep Reading

Most Popular

Large language models can do jaw-dropping things. But nobody knows exactly why.

And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.

The problem with plug-in hybrids? Their drivers.

Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

Google DeepMind’s new generative model makes Super Mario–like games from scratch

Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.